RankingsPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Total current assets

Nxera Pharma Co., Ltd.【JP:4565】

Market cap
¥78.2B
P/E ratio
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Dec 31, 202457,855-11.15%
Dec 31, 202365,112-6.91%
Dec 31, 202269,942+11.36%
Dec 31, 202162,808+49.48%
Dec 31, 202042,018+114.78%
Dec 31, 201919,563-9.14%
Dec 31, 201821,530-11.07%
Mar 31, 201824,211+714.64%
Mar 31, 20172,972-60.09%
Mar 31, 20167,447+169.72%
Mar 31, 20152,761

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)